Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis.
Jesus MM, Lage DP, Vale DL, Freitas CS, Pimenta BL, Moreira GJL, Ramos FF, Pereira IAG, Bandeira RS, Ludolf F, Tavares GSV, Galdino AS, Duarte MC, Menezes-Souza D, Chávez-Fumagalli MA, Teixeira AL, Gonçalves DU, Roatt BM, Christodoulides M, Martins VT, Coelho EAF. Jesus MM, et al. Among authors: bandeira rs. Parasitol Res. 2023 Dec;122(12):2917-2931. doi: 10.1007/s00436-023-07981-6. Epub 2023 Sep 28. Parasitol Res. 2023. PMID: 37768367
A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human disease.
Machado AS, Ramos FF, Santos TTO, Costa LE, Ludolf F, Lage DP, Bandeira RS, Tavares GSV, Oliveira-da-Silva JA, Steiner BT, Chaves AT, Oliveira JS, Chávez-Fumagalli MA, de Magalhães-Soares DF, Silveira JAG, Duarte MC, Machado-de-Ávila RA, Lyon S, Gonçalves DU, Caligiorne RB, Coelho EAF. Machado AS, et al. Among authors: bandeira rs. Exp Parasitol. 2020 Sep;216:107941. doi: 10.1016/j.exppara.2020.107941. Epub 2020 Jul 2. Exp Parasitol. 2020. PMID: 32622940
A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis.
Oliveira-da-Silva JA, Machado AS, Ramos FF, Tavares GSV, Lage DP, Mendonça DVC, Pereira IAG, Santos TTO, Martins VT, Carvalho LM, Freitas CS, Ludolf F, Reis TAR, Bandeira RS, Silva AM, Costa LE, Oliveira JS, Duarte MC, Roatt BM, Teixeira AL, Coelho EAF. Oliveira-da-Silva JA, et al. Among authors: bandeira rs. Cell Immunol. 2020 Oct;356:104194. doi: 10.1016/j.cellimm.2020.104194. Epub 2020 Aug 13. Cell Immunol. 2020. PMID: 32827943
Sensitive and specific serodiagnosis of tegumentary leishmaniasis using a new chimeric protein based on specific B-cell epitopes of Leishmania antigenic proteins.
Galvani NC, Machado AS, Lage DP, Martins VT, de Oliveira D, Freitas CS, Vale DL, Fernandes BB, Oliveira-da-Silva JA, Reis TAR, Santos TTO, Ramos FF, Bandeira RS, Ludolf F, Tavares GSV, Guimarães NS, Tupinambás U, Chávez-Fumagalli MA, Humbert MV, Gonçalves DU, Christodoulides M, Machado-de-Ávila RA, Coelho EAF. Galvani NC, et al. Among authors: bandeira rs. Microb Pathog. 2022 Jan;162:105341. doi: 10.1016/j.micpath.2021.105341. Epub 2021 Dec 6. Microb Pathog. 2022. PMID: 34883228
Diagnostic application of sensitive and specific phage-exposed epitopes for visceral leishmaniasis and human immunodeficiency virus coinfection.
Ramos FF, Tavares GSV, Ludolf F, Machado AS, Santos TTO, Gonçalves IAP, Dias ACS, Alves PT, Fraga VG, Bandeira RS, Oliveira-da-Silva JA, Reis TAR, Lage DP, Martins VT, Freitas CS, Chaves AT, Guimarães NS, Chávez-Fumagalli MA, Tupinambás U, Rocha MOC, Cota GF, Fujiwara RT, Bueno LL, Goulart LR, Coelho EAF. Ramos FF, et al. Among authors: bandeira rs. Parasitology. 2021 Nov;148(13):1706-1714. doi: 10.1017/S0031182021001505. Epub 2021 Aug 19. Parasitology. 2021. PMID: 35060464 Free PMC article.
Recombinant endonuclease III protein from Leishmania infantum associated with Th1-type adjuvants is immunogenic and induces protection against visceral leishmaniasis.
Lage DP, Machado AS, Freitas CS, Vale DL, Linhares FP, Cardoso JMO, Oliveira-da-Silva JA, Ramos FF, Pereira IAG, Ludolf F, Tavares GSV, Bandeira RS, Oliveira JS, Menezes-Souza D, Duarte MC, Galdino AS, Christodoulides M, Chávez-Fumagalli MA, Roatt BM, Martins VT, Coelho EAF. Lage DP, et al. Among authors: bandeira rs. Mol Immunol. 2023 Mar;155:79-90. doi: 10.1016/j.molimm.2023.01.011. Epub 2023 Jan 31. Mol Immunol. 2023. PMID: 36731193
Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis.
Freitas CS, Lage DP, Machado AS, Vale DL, Martins VT, Cardoso JMO, Oliveira-da-Silva JA, Reis TAR, Tavares GSV, Ramos FF, Ludolf F, Pereira IAG, Bandeira RS, Fujiwara RT, Bueno LL, Roatt BM, Chávez-Fumagalli MA, Coelho EAF. Freitas CS, et al. Among authors: bandeira rs. Cytokine. 2023 Apr;164:156143. doi: 10.1016/j.cyto.2023.156143. Epub 2023 Feb 10. Cytokine. 2023. PMID: 36774730
In vitro evaluation of antileishmanial activity, mode of action and cellular response induced by vanillin synthetic derivatives against Leishmania species able to cause cutaneous and visceral leishmaniasis.
Freitas CS, Santiago SS, Lage DP, Antinarelli LMR, Oliveira FM, Vale DL, Martins VT, Magalhaes LND, Bandeira RS, Ramos FF, Pereira IAG, de Jesus MM, Ludolf F, Tavares GSV, Costa AV, Ferreira RS, Coimbra ES, Teixeira RR, Coelho EAF. Freitas CS, et al. Among authors: bandeira rs. Exp Parasitol. 2023 Aug;251:108555. doi: 10.1016/j.exppara.2023.108555. Epub 2023 May 27. Exp Parasitol. 2023. PMID: 37247802
Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis.
Vale DL, Freitas CS, Martins VT, Moreira GJL, Machado AS, Ramos FF, Pereira IAG, Bandeira RS, de Jesus MM, Tavares GSV, Ludolf F, Chávez-Fumagalli MA, Galdino AS, Fujiwara RT, Bueno LL, Roatt BM, Christodoulides M, Coelho EAF, Lage DP. Vale DL, et al. Among authors: bandeira rs. Biology (Basel). 2023 Jun 13;12(6):851. doi: 10.3390/biology12060851. Biology (Basel). 2023. PMID: 37372136 Free PMC article.
The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice.
Lage DP, Martins VT, Vale DL, Freitas CS, Pimenta BL, Moreira GJL, Ramos FF, Pereira IAG, Bandeira RS, de Jesus MM, Ludolf F, Tavares GSV, Chávez-Fumagalli MA, Roatt BM, Christodoulides M, Coelho EAF. Lage DP, et al. Among authors: bandeira rs. Acta Trop. 2023 Oct;246:106986. doi: 10.1016/j.actatropica.2023.106986. Epub 2023 Jul 14. Acta Trop. 2023. PMID: 37453579
37 results